Geologists wish to find out how high valleys with the characteristics of Shangri-La came into being

Time to bust myth that anyone–including athletes–can outrun a bad diet

Scientists have demonstrated the potential for softwoods to process more easily into pulp and paper if engineered to incorporate a key feature of hardwoods. The finding, published in this week's Proceedings of the National Academy of Sciences, could improve the economics of the pulp, paper and biofuels industries and reduce those industries' environmental impact.

Scientists at The Scripps Research Institute (TSRI) have been awarded two grants to study brain mechanisms that actively suppress relapse associated with cocaine and alcohol addiction.

Strategic technology deal strengthens IDBS’ single R&D data management platform.

Florida Atlantic University, one of Florida’s leading public research universities, and the internationally renowned Nansen Neuroscience Network (NNN) in Norway, a premier network of organizations dedicated to research into neuroscience in Europe, have signed a memorandum of understanding for cooperative research and education in the areas of neuroscience and brain health.

The workings of the ingredient capsaicin in calming nerves become more clear in a Newark lab.

Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront of drug discovery. So drug companies want a faster route to step one: identifying which of the millions of possible antibodies will work against molecules that cause disease.

3-D printing has been used to make everything from cars to medical implants. Now, University of Washington ecologists are using the technology to make artificial flowers, which they say could revolutionize our understanding of plant-pollinator interactions.

Instrument driver exchange enhances laboratory efficiency, flexibility.

ESF faculty: human population, lack of knowledge are planet’s biggest challenges.

Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, today (Apr. 20) announced it has signed a supply and commercialization agreement with Thermo Fisher Scientific, the world leader in serving science.